{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:44:46Z","timestamp":1790995486703,"version":"4.1.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T00:00:00Z","timestamp":1400630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s12016-014-8424-0","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T00:57:45Z","timestamp":1400547465000},"page":"73-90","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The Clinical Significance of Posttranslational Modification of Autoantigens"],"prefix":"10.1007","volume":"47","author":[{"given":"Maria G.","family":"Zavala-Cerna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika A.","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Torres-Bugar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjam\u00edn","family":"Rubio-Jurado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Riebeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnulfo","family":"Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,21]]},"reference":[{"key":"8424_CR1","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.337487","volume":"198","author":"R Uy","year":"1977","unstructured":"Uy R, Wold F (1977) Posttranslational covalent modification of proteins. Science 198:890\u2013896","journal-title":"Science"},{"key":"8424_CR2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5483\/BMBRep.2004.37.1.035","volume":"37","author":"J Seo","year":"2004","unstructured":"Seo J, Lee KJ (2004) Post-translational modifications and their biological functions: proteomic analysis and systematic approaches. J Biochem Mol Biol 37:35\u201344","journal-title":"J Biochem Mol Biol"},{"key":"8424_CR3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0092-8674(03)00354-4","volume":"113","author":"JU Baenziger","year":"2003","unstructured":"Baenziger JU (2003) A major step on the road to understanding a unique posttranslational modification and its role in a genetic disease. Cell 113:421\u2013422","journal-title":"Cell"},{"key":"8424_CR4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nbt0303-255","volume":"21","author":"M Mann","year":"2003","unstructured":"Mann M, Jensen ON (2003) Proteomic analysis of post-translational modifications. Nat Biotechnol 21:255\u2013261","journal-title":"Nat Biotechnol"},{"key":"8424_CR5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbamcr.2004.09.021","volume":"1695","author":"RJ Dohmen","year":"2004","unstructured":"Dohmen RJ (2004) SUMO protein modification. Biochim Biophys Acta 1695:113\u2013131","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 5","key":"8424_CR6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0959-8049(02)80597-4","volume":"38","author":"T Pawson","year":"2002","unstructured":"Pawson T (2002) Regulation and targets of receptor tyrosine kinases. Eur J Cancer 38(Suppl 5):S3\u2013S10","journal-title":"Eur J Cancer"},{"key":"8424_CR7","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/emboj\/19.6.1176","volume":"19","author":"T Kouzarides","year":"2000","unstructured":"Kouzarides T (2000) Acetylation: a regulatory modification to rival phosphorylation? EMBO J 19:1176\u20131179","journal-title":"EMBO J"},{"key":"8424_CR8","doi-asserted-by":"crossref","first-page":"pe26","DOI":"10.1126\/stke.2003.190.pe26","volume":"2003","author":"JH Schwartz","year":"2003","unstructured":"Schwartz JH (2003) Ubiquitination, protein turnover, and long-term synaptic plasticity. Sci STKE 2003:pe26","journal-title":"Sci STKE"},{"key":"8424_CR9","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nrm1200","volume":"4","author":"JS Seeler","year":"2003","unstructured":"Seeler JS, Dejean A (2003) Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol 4:690\u2013699","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8424_CR10","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1021\/bi953063g","volume":"35","author":"J Najbauer","year":"1996","unstructured":"Najbauer J, Orpiszewski J, Aswad DW (1996) Molecular aging of tubulin: accumulation of isoaspartyl sites in vitro and in vivo. Biochemistry 35:5183\u20135190","journal-title":"Biochemistry"},{"key":"8424_CR11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/ar75","volume":"2","author":"PJ Utz","year":"2000","unstructured":"Utz PJ, Gensler TJ, Anderson P (2000) Death, autoantigen modifications, and tolerance. Arthritis Res 2:101\u2013114","journal-title":"Arthritis Res"},{"key":"8424_CR12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.coi.2011.12.003","volume":"24","author":"HA Doyle","year":"2011","unstructured":"Doyle HA, Mamula MJ (2011) Autoantigenesis: the evolution of protein modifications in autoimmune disease. Curr Opin Immunol 24:112\u2013118","journal-title":"Curr Opin Immunol"},{"key":"8424_CR13","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1073\/pnas.80.8.2346","volume":"80","author":"RS Fujinami","year":"1983","unstructured":"Fujinami RS, Oldstone MB, Wroblewska Z, Frankel ME, Koprowski H (1983) Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A 80:2346\u20132350","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8424_CR14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","volume":"42","author":"MF Cusick","year":"2012","unstructured":"Cusick MF, Libbey JE, Fujinami RS (2012) Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol 42:102\u2013111","journal-title":"Clin Rev Allergy Immunol"},{"key":"8424_CR15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(85)90352-6","volume":"2","author":"A Ebringer","year":"1985","unstructured":"Ebringer A, Ptaszynska T, Corbett M, Wilson C, Macafee Y, Avakian H, Baron P, James DC (1985) Antibodies to proteus in rheumatoid arthritis. Lancet 2:305\u2013307","journal-title":"Lancet"},{"key":"8424_CR16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00262713","volume":"15","author":"M Fielder","year":"1995","unstructured":"Fielder M, Tiwana H, Youinou P, Le Goff P, Deonarain R, Wilson C, Ebringer A (1995) The specificity of the anti-Proteus antibody response in tissue-typed rheumatoid arthritis (RA) patients from Brest. Rheumatol Int 15:79\u201382","journal-title":"Rheumatol Int"},{"key":"8424_CR17","first-page":"109","volume":"24","author":"Y Tani","year":"1997","unstructured":"Tani Y, Tiwana H, Hukuda S, Nishioka J, Fielder M, Wilson C, Bansal S, Ebringer A (1997) Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 24:109\u2013114","journal-title":"J Rheumatol"},{"key":"8424_CR18","first-page":"39","volume":"105","author":"A Wanchu","year":"1997","unstructured":"Wanchu A, Deodhar SD, Sharma M, Gupta V, Bambery P, Sud A (1997) Elevated levels of anti-proteus antibodies in patients with active rheumatoid arthritis. Indian J Med Res 105:39\u201342","journal-title":"Indian J Med Res"},{"key":"8424_CR19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s100670050083","volume":"18","author":"T Rashid","year":"1999","unstructured":"Rashid T, Darlington G, Kjeldsen-Kragh J, Forre O, Collado A, Ebringer A (1999) Proteus IgG antibodies and C-reactive protein in English, Norwegian and Spanish patients with rheumatoid arthritis. Clin Rheumatol 18:190\u2013195","journal-title":"Clin Rheumatol"},{"key":"8424_CR20","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/rheumatology\/kei036","volume":"44","author":"MM Newkirk","year":"2005","unstructured":"Newkirk MM, Goldbach-Mansky R, Senior BW, Klippel J, Schumacher HR Jr, El-Gabalawy HS (2005) Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Rheumatology (Oxford) 44:1433\u20131441","journal-title":"Rheumatology (Oxford)"},{"key":"8424_CR21","doi-asserted-by":"crossref","unstructured":"Ebringer A, Cunningham P, Ahmadi K, Wrigglesworth J, Hosseini R, Wilson C (1992) Sequence similarity between HLA-DR1 and DR4 subtypes associated with rheumatoid arthritis and proteus\/serratia membrane haemolysins. Ann Rheum Dis 51:1245\u20136","DOI":"10.1136\/ard.51.11.1245"},{"key":"8424_CR22","doi-asserted-by":"crossref","unstructured":"Wilson C, Ebringer A, Ahmadi K, Wrigglesworth J, Tiwana H, Fielder M, Binder A, Ettelaie C, Cunningham P, Joannou C, et al. (1995) Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis. Ann Rheum Dis 54:216\u201320","DOI":"10.1136\/ard.54.3.216"},{"key":"8424_CR23","doi-asserted-by":"crossref","unstructured":"Senior BW, Anderson GA, Morley KD, Kerr MA (1999) Evidence that patients with rheumatoid arthritis have asymptomatic 'non-significant' Proteus mirabilis bacteriuria more frequently than healthy controls. J Infect 38:99\u2013106","DOI":"10.1016\/S0163-4453(99)90076-2"},{"key":"8424_CR24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1172\/JCI115580","volume":"89","author":"S Albani","year":"1992","unstructured":"Albani S, Tuckwell JE, Esparza L, Carson DA, Roudier J (1992) The susceptibility sequence to rheumatoid arthritis is a cross-reactive B cell epitope shared by the Escherichia coli heat shock protein dnaJ and the histocompatibility leukocyte antigen DRB10401 molecule. J Clin Invest 89:327\u2013331","journal-title":"J Clin Invest"},{"key":"8424_CR25","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI110127","volume":"67","author":"MA Alspaugh","year":"1981","unstructured":"Alspaugh MA, Henle G, Lennette ET, Henle W (1981) Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest 67:1134\u20131140","journal-title":"J Clin Invest"},{"key":"8424_CR26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-60761-800-3_13","volume":"662","author":"VC Kyttaris","year":"2013","unstructured":"Kyttaris VC (2013) Systemic lupus erythematosus: from genes to organ damage. Methods Mol Biol 662:265\u2013283","journal-title":"Methods Mol Biol"},{"key":"8424_CR27","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/elps.201200058","volume":"33","author":"K Nagai","year":"2012","unstructured":"Nagai K, Arito M, Takakuwa Y, Ooka S, Sato T, Kurokawa MS, Okamoto K, Uchida T, Suematsu N, Kato T (2012) Altered posttranslational modification on U1 small nuclear ribonucleoprotein 68k in systemic autoimmune diseases detected by 2D Western blot. Electrophoresis 33:2028\u20132035","journal-title":"Electrophoresis"},{"key":"8424_CR28","doi-asserted-by":"crossref","first-page":"e53129","DOI":"10.1371\/journal.pone.0053129","volume":"7","author":"X Zhang","year":"2013","unstructured":"Zhang X, Ma H, Huang J, Dai Y (2013) Characterization of the phosphoproteome in SLE patients. PLoS One 7:e53129","journal-title":"PLoS One"},{"key":"8424_CR29","first-page":"343","volume":"47","author":"J Dieker","year":"2009","unstructured":"Dieker J, Muller S (2009) Post-translational modifications, subcellular relocation and release in apoptotic microparticles: apoptosis turns nuclear proteins into autoantigens. Folia Histochem Cytobiol 47:343\u2013348","journal-title":"Folia Histochem Cytobiol"},{"key":"8424_CR30","doi-asserted-by":"crossref","unstructured":"Saal JG, Steidle M, Einsele H, Muller CA, Fritz P, Zacher J (1992) Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int 12:147\u201351","DOI":"10.1007\/BF00274934"},{"key":"8424_CR31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s12026-013-8420-0","volume":"56","author":"M Dolcino","year":"2013","unstructured":"Dolcino M, Zanoni G, Bason C, Tinazzi E, Boccola E, Valletta E, Contreas G, Lunardi C, Puccetti A (2013) A subset of anti-rotavirus antibodies directed against the viral protein VP7 predicts the onset of celiac disease and induces typical features of the disease in the intestinal epithelial cell line T84. Immunol Res 56:465\u2013476","journal-title":"Immunol Res"},{"key":"8424_CR32","doi-asserted-by":"crossref","unstructured":"Cunningham MW, McCormack JM, Fenderson PG, Ho MK, Beachey EH, Dale JB (1989) Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol 143:2677\u20132683","DOI":"10.4049\/jimmunol.143.8.2677"},{"key":"8424_CR33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1189\/jlb.0709517","volume":"87","author":"P Sfriso","year":"2010","unstructured":"Sfriso P, Ghirardello A, Botsios C, Tonon M, Zen M, Bassi N, Bassetto F, Doria A (2010) Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol 87:385\u2013395","journal-title":"J Leukoc Biol"},{"key":"8424_CR34","doi-asserted-by":"crossref","unstructured":"Shahrizaila N, Yuki N. Guillain-Barre syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder. J Biomed Biotechnol 2011: 829129","DOI":"10.1155\/2011\/829129"},{"key":"8424_CR35","first-page":"564","volume":"27","author":"LJ Albert","year":"2000","unstructured":"Albert LJ (2000) Infection and rheumatoid arthritis: guilt by association? J Rheumatol 27:564\u2013566","journal-title":"J Rheumatol"},{"key":"8424_CR36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3855\/jidc.2061","volume":"5","author":"LG Delogu","year":"2011","unstructured":"Delogu LG, Deidda S, Delitala G, Manetti R (2011) Infectious diseases and autoimmunity. J Infect Dev Ctries 5:679\u2013687","journal-title":"J Infect Dev Ctries"},{"key":"8424_CR37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nri2527","volume":"9","author":"C Munz","year":"2009","unstructured":"Munz C, Lunemann JD, Getts MT, Miller SD (2009) Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 9:246\u2013258","journal-title":"Nat Rev Immunol"},{"key":"8424_CR38","doi-asserted-by":"crossref","first-page":"15028","DOI":"10.1073\/pnas.0806619105","volume":"105","author":"BA Croker","year":"2008","unstructured":"Croker BA, Lawson BR, Rutschmann S, Berger M, Eidenschenk C, Blasius AL, Moresco EM, Sovath S, Cengia L, Shultz LD, Theofilopoulos AN, Pettersson S, Beutler BA (2008) Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger. Proc Natl Acad Sci U S A 105:15028\u201315033","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8424_CR39","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.22042","volume":"47","author":"ME Gershwin","year":"2008","unstructured":"Gershwin ME, Mackay IR (2008) The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 47:737\u2013745","journal-title":"Hepatology"},{"key":"8424_CR40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.22390","volume":"48","author":"K Wakabayashi","year":"2008","unstructured":"Wakabayashi K, Lian ZX, Leung PS, Moritoki Y, Tsuneyama K, Kurth MJ, Lam KS, Yoshida K, Yang GX, Hibi T, Ansari AA, Ridgway WM, Coppel RL, Mackay IR, Gershwin ME (2008) Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 48:531\u2013540","journal-title":"Hepatology"},{"key":"8424_CR41","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.179.4.2651","volume":"179","author":"PS Leung","year":"2007","unstructured":"Leung PS, Park O, Tsuneyama K, Kurth MJ, Lam KS, Ansari AA, Coppel RL, Gershwin ME (2007) Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol 179:2651\u20132657","journal-title":"J Immunol"},{"key":"8424_CR42","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1189\/jlb.70.6.849","volume":"70","author":"A Billiau","year":"2001","unstructured":"Billiau A, Matthys P (2001) Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J Leukoc Biol 70:849\u2013860","journal-title":"J Leukoc Biol"},{"key":"8424_CR43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/1074-7613(94)90101-5","volume":"1","author":"MG Herrath von","year":"1994","unstructured":"von Herrath MG, Dockter J, Oldstone MB (1994) How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1:231\u2013242","journal-title":"Immunity"},{"key":"8424_CR44","doi-asserted-by":"crossref","unstructured":"Getts MT, Miller SD. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: triggering of autoimmune diseases by infections. Clin Exp Immunol 160: 15-21","DOI":"10.1111\/j.1365-2249.2010.04132.x"},{"key":"8424_CR45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/ar4074","volume":"14","author":"K Klein","year":"2012","unstructured":"Klein K, Ospelt C, Gay S (2012) Epigenetic contributions in the development of rheumatoid arthritis. Arthritis Res Ther 14:227","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 2","key":"8424_CR46","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1007\/s10198-007-0087-9","volume":"8","author":"J Smolen","year":"2008","unstructured":"Smolen J, Aletaha D (2008) The burden of rheumatoid arthritis and access to treatment: a medical overview. Eur J Health Econ 8(Suppl 2):S39\u2013S47","journal-title":"Eur J Health Econ"},{"key":"8424_CR47","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.autrev.2005.04.018","volume":"4","author":"B Vander Cruyssen","year":"2005","unstructured":"Vander Cruyssen B, Peene I, Cantaert T, Hoffman IE, De Rycke L, Veys EM, De Keyser F (2005) Anti-citrullinated protein\/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor. Autoimmun Rev 4:468\u2013474","journal-title":"Autoimmun Rev"},{"key":"8424_CR48","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00296-009-0854-2","volume":"29","author":"E Wagner","year":"2009","unstructured":"Wagner E, Skoumal M, Bayer PM, Klaushofer K (2009) Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis. Rheumatol Int 29:1315\u20131321","journal-title":"Rheumatol Int"},{"key":"8424_CR49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"GA Schellekens","year":"1998","unstructured":"Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101:273\u2013281","journal-title":"J Clin Invest"},{"key":"8424_CR50","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50:380\u2013386","journal-title":"Arthritis Rheum"},{"key":"8424_CR51","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","volume":"50","author":"FA Gaalen van","year":"2004","unstructured":"van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes RE, Huizinga TW (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50:709\u2013715","journal-title":"Arthritis Rheum"},{"key":"8424_CR52","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.molmed.2003.09.010","volume":"9","author":"R Yamada","year":"2003","unstructured":"Yamada R, Suzuki A, Chang X, Yamamoto K (2003) Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene. Trends Mol Med 9:503\u2013508","journal-title":"Trends Mol Med"},{"key":"8424_CR53","first-page":"1654","volume":"31","author":"H Takahara","year":"1986","unstructured":"Takahara H, Sugawara K (1986) Peptidylarginine deiminase, protein-arginine deiminase and protein-L-arginine iminohydrolase. Tanpakushitsu Kakusan Koso 31:1654\u20131660","journal-title":"Tanpakushitsu Kakusan Koso"},{"key":"8424_CR54","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/bies.10357","volume":"25","author":"ER Vossenaar","year":"2003","unstructured":"Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ (2003) PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25:1106\u20131118","journal-title":"Bioessays"},{"key":"8424_CR55","doi-asserted-by":"crossref","first-page":"49562","DOI":"10.1074\/jbc.M208795200","volume":"277","author":"K Nakashima","year":"2002","unstructured":"Nakashima K, Hagiwara T, Yamada M (2002) Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. J Biol Chem 277:49562\u201349568","journal-title":"J Biol Chem"},{"key":"8424_CR56","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1021\/bi061180d","volume":"45","author":"Y Luo","year":"2006","unstructured":"Luo Y, Arita K, Bhatia M, Knuckley B, Lee YH, Stallcup MR, Sato M, Thompson PR (2006) Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization. Biochemistry 45:11727\u201311736","journal-title":"Biochemistry"},{"key":"8424_CR57","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1006\/bbrc.1996.1240","volume":"225","author":"T Senshu","year":"1996","unstructured":"Senshu T, Kan S, Ogawa H, Manabe M, Asaga H (1996) Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis. Biochem Biophys Res Commun 225:712\u2013719","journal-title":"Biochem Biophys Res Commun"},{"key":"8424_CR58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(99)00276-1","volume":"266","author":"LB Pritzker","year":"1999","unstructured":"Pritzker LB, Nguyen TA, Moscarello MA (1999) The developmental expression and activity of peptidylarginine deiminase in the mouse. Neurosci Lett 266:161\u2013164","journal-title":"Neurosci Lett"},{"key":"8424_CR59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1083\/jcb.200806072","volume":"184","author":"Y Wang","year":"2009","unstructured":"Wang Y, Li M, Stadler S, Correll S, Li P, Wang D, Hayama R, Leonelli L, Han H, Grigoryev SA, Allis CD, Coonrod SA (2009) Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 184:205\u2013213","journal-title":"J Cell Biol"},{"key":"8424_CR60","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1146\/annurev.immunol.19.1.497","volume":"19","author":"RS Lewis","year":"2001","unstructured":"Lewis RS (2001) Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol 19:497\u2013521","journal-title":"Annu Rev Immunol"},{"key":"8424_CR61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/BC.2009.019","volume":"390","author":"ME Stensland","year":"2009","unstructured":"Stensland ME, Pollmann S, Molberg O, Sollid LM, Fleckenstein B (2009) Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4. Biol Chem 390:99\u2013107","journal-title":"Biol Chem"},{"key":"8424_CR62","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2003.012211","volume":"63","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, Radstake TR, van der Heijden A, van Mansum MA, Dieteren C, de Rooij DJ, Barrera P, Zendman AJ, van Venrooij WJ (2004) Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 63:373\u2013381","journal-title":"Ann Rheum Dis"},{"key":"8424_CR63","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.20584","volume":"50","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, Smeets TJ, Kraan MC, Raats JM, van Venrooij WJ, Tak PP (2004) The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 50:3485\u20133494","journal-title":"Arthritis Rheum"},{"key":"8424_CR64","doi-asserted-by":"crossref","first-page":"R458","DOI":"10.1186\/ar1697","volume":"7","author":"K Lundberg","year":"2005","unstructured":"Lundberg K, Nijenhuis S, Vossenaar ER, Palmblad K, van Venrooij WJ, Klareskog L, Zendman AJ, Harris HE (2005) Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 7:R458\u2013R467","journal-title":"Arthritis Res Ther"},{"key":"8424_CR65","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/ard.2009.126821","volume":"70","author":"L Padyukov","year":"2013","unstructured":"Padyukov L, Seielstad M, Ong RT, Ding B, Ronnelid J, Seddighzadeh M, Alfredsson L, Klareskog L (2013) A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann Rheum Dis 70:259\u2013265","journal-title":"Ann Rheum Dis"},{"key":"8424_CR66","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155\u2013163","journal-title":"Arthritis Rheum"},{"key":"8424_CR67","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.2003.016808","volume":"63","author":"A Kastbom","year":"2004","unstructured":"Kastbom A, Strandberg G, Lindroos A, Skogh T (2004) Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 63:1085\u20131089","journal-title":"Ann Rheum Dis"},{"key":"8424_CR68","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2249.2004.02708.x","volume":"139","author":"S Chapuy-Regaud","year":"2005","unstructured":"Chapuy-Regaud S, Nogueira L, Clavel C, Sebbag M, Vincent C, Serre G (2005) IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol 139:542\u2013550","journal-title":"Clin Exp Immunol"},{"key":"8424_CR69","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/ard.2005.044743","volume":"65","author":"Y Takizawa","year":"2006","unstructured":"Takizawa Y, Suzuki A, Sawada T, Ohsaka M, Inoue T, Yamada R, Yamamoto K (2006) Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids. Ann Rheum Dis 65:1013\u20131020","journal-title":"Ann Rheum Dis"},{"key":"8424_CR70","doi-asserted-by":"crossref","unstructured":"Van Steendam K, Tilleman K, De Ceuleneer M, De Keyser F, Elewaut D, Deforce D. Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins. Arthritis Res Ther 12: R132","DOI":"10.1186\/ar3070"},{"key":"8424_CR71","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bbrc.2005.05.137","volume":"333","author":"A Suzuki","year":"2005","unstructured":"Suzuki A, Yamada R, Ohtake-Yamanaka M, Okazaki Y, Sawada T, Yamamoto K (2005) Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis. Biochem Biophys Res Commun 333:418\u2013426","journal-title":"Biochem Biophys Res Commun"},{"key":"8424_CR72","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1186\/ar1845","volume":"7","author":"A Kinloch","year":"2005","unstructured":"Kinloch A, Tatzer V, Wait R, Peston D, Lundberg K, Donatien P, Moyes D, Taylor PC, Venables PJ (2005) Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 7:R1421\u2013R1429","journal-title":"Arthritis Res Ther"},{"key":"8424_CR73","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/BOR.0b013e32835fd8eb","volume":"25","author":"C Pitzalis","year":"2013","unstructured":"Pitzalis C, Kelly S, Humby F (2013) New learnings on the pathophysiology of RA from synovial biopsies. Curr Opin Rheumatol 25:334\u2013344","journal-title":"Curr Opin Rheumatol"},{"key":"8424_CR74","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.20121486","volume":"210","author":"K Amara","year":"2013","unstructured":"Amara K, Steen J, Murray F, Morbach H, Fernandez-Rodriguez BM, Joshua V, Engstrom M, Snir O, Israelsson L, Catrina AI, Wardemann H, Corti D, Meffre E, Klareskog L, Malmstrom V (2013) Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J Exp Med 210:445\u2013455","journal-title":"J Exp Med"},{"key":"8424_CR75","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/pmic.201200452","volume":"13","author":"L Kollipara","year":"2013","unstructured":"Kollipara L, Zahedi RP (2013) Protein carbamylation: in vivo modification or in vitro artefact. Proteomics 13:941\u2013944","journal-title":"Proteomics"},{"key":"8424_CR76","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.22206","volume":"54","author":"T Cantaert","year":"2006","unstructured":"Cantaert T, De Rycke L, Bongartz T, Matteson EL, Tak PP, Nicholas AP, Baeten D (2006) Citrullinated proteins in rheumatoid arthritis: crucial\u2026but not sufficient! Arthritis Rheum 54:3381\u20133389","journal-title":"Arthritis Rheum"},{"key":"8424_CR77","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(09)60008-8","volume":"373","author":"L Klareskog","year":"2009","unstructured":"Klareskog L, Catrina AI, Paget S (2009) Rheumatoid arthritis. Lancet 373:659\u2013672","journal-title":"Lancet"},{"key":"8424_CR78","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.37830","volume":"65","author":"J Shi","year":"2013","unstructured":"Shi J, van de Stadt LA, Levarht EW, Huizinga TW, Toes RE, Trouw LA, van Schaardenburg D (2013) Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis Rheum 65:911\u2013915","journal-title":"Arthritis Rheum"},{"key":"8424_CR79","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nm1637","volume":"13","author":"Z Wang","year":"2007","unstructured":"Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Horkko S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL (2007) Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 13:1176\u20131184","journal-title":"Nat Med"},{"key":"8424_CR80","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/scitranslmed.3005580","volume":"5","author":"R Khandpur","year":"2013","unstructured":"Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, Friday S, Li S, Patel RM, Subramanian V, Thompson P, Chen P, Fox DA, Pennathur S, Kaplan MJ (2013) NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 5:178","journal-title":"Sci Transl Med"},{"key":"8424_CR81","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-5793(04)00233-9","volume":"563","author":"R Garnotel","year":"2004","unstructured":"Garnotel R, Sabbah N, Jaisson S, Gillery P (2004) Enhanced activation of and increased production of matrix metalloproteinase-9 by human blood monocytes upon adhering to carbamylated collagen. FEBS Lett 563:13\u201316","journal-title":"FEBS Lett"},{"key":"8424_CR82","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.febslet.2007.03.008","volume":"581","author":"S Jaisson","year":"2007","unstructured":"Jaisson S, Delevallee-Forte C, Toure F, Rieu P, Garnotel R, Gillery P (2007) Carbamylated albumin is a potent inhibitor of polymorphonuclear neutrophil respiratory burst. FEBS Lett 581:1509\u20131513","journal-title":"FEBS Lett"},{"key":"8424_CR83","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.4049\/jimmunol.1000075","volume":"184","author":"P Mydel","year":"2010","unstructured":"Mydel P, Wang Z, Brisslert M, Hellvard A, Dahlberg LE, Hazen SL, Bokarewa M, Mydel P, Wang Z, Brisslert M, Hellvard A, Dahlberg LE, Hazen SL, Bokarewa M (2010) Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis. J Immunol 184:6882\u20136890","journal-title":"J Immunol"},{"key":"8424_CR84","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/annrheumdis-2012-201559","volume":"72","author":"J Shi","year":"2013","unstructured":"Shi J, Willemze A, Janssen GM, van Veelen PA, Drijfhout JW, Cerami A, Huizinga TW, Trouw LA, Toes RE (2013) Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the 'AMC-Senshu' method. Ann Rheum Dis 72:148\u2013150","journal-title":"Ann Rheum Dis"},{"key":"8424_CR85","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm.2050","volume":"15","author":"S Lefevre","year":"2009","unstructured":"Lefevre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R, Korb A, Schnaker EM, Tarner IH, Robbins PD, Evans CH, Sturz H, Steinmeyer J, Gay S, Scholmerich J, Pap T, Muller-Ladner U, Neumann E (2009) Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 15:1414\u20131420","journal-title":"Nat Med"},{"key":"8424_CR86","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.berh.2008.01.004","volume":"22","author":"C Ospelt","year":"2008","unstructured":"Ospelt C, Gay S (2008) The role of resident synovial cells in destructive arthritis. Best Pract Res Clin Rheumatol 22:239\u2013252","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8424_CR87","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2009.06.049","volume":"138","author":"Z Wang","year":"2009","unstructured":"Wang Z, Zang C, Cui K, Schones DE, Barski A, Peng W, Zhao K (2009) Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 138:1019\u20131031","journal-title":"Cell"},{"key":"8424_CR88","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/ar3137","volume":"12","author":"AM Grabiec","year":"2010","unstructured":"Grabiec AM, Reedquist KA (2010) Histone deacetylases in RA: epigenetics and epiphenomena. Arthritis Res Ther 12:142","journal-title":"Arthritis Res Ther"},{"key":"8424_CR89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/47412","volume":"403","author":"BD Strahl","year":"2000","unstructured":"Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403:41\u201345","journal-title":"Nature"},{"key":"8424_CR90","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1136\/ard.2010.143040","volume":"70","author":"M Trenkmann","year":"2011","unstructured":"Trenkmann M, Brock M, Gay RE, Kolling C, Speich R, Michel BA, Gay S, Huber LC (2011) Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis. Ann Rheum Dis 70:1482\u20131488","journal-title":"Ann Rheum Dis"},{"key":"8424_CR91","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0006-291X(02)00699-X","volume":"295","author":"MS Jang","year":"2002","unstructured":"Jang MS, Ryu SW, Kim E (2002) Modification of Daxx by small ubiquitin-related modifier-1. Biochem Biophys Res Commun 295:495\u2013500","journal-title":"Biochem Biophys Res Commun"},{"key":"8424_CR92","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.4049\/jimmunol.157.10.4277","volume":"157","author":"T Okura","year":"1996","unstructured":"Okura T, Gong L, Kamitani T, Wada T, Okura I, Wei CF, Chang HM, Yeh ET (1996) Protection against Fas\/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J Immunol 157:4277\u20134281","journal-title":"J Immunol"},{"key":"8424_CR93","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1073\/pnas.0608773104","volume":"104","author":"I Meinecke","year":"2007","unstructured":"Meinecke I, Cinski A, Baier A, Peters MA, Dankbar B, Wille A, Drynda A, Mendoza H, Gay RE, Hay RT, Ink B, Gay S, Pap T (2007) Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. Proc Natl Acad Sci U S A 104:5073\u20135078","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8424_CR94","first-page":"559","volume":"27","author":"A Ebringer","year":"2000","unstructured":"Ebringer A, Wilson C, Tiwana H (2000) Is rheumatoid arthritis a form of reactive arthritis? J Rheumatol 27:559\u2013563","journal-title":"J Rheumatol"},{"key":"8424_CR95","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.autrev.2009.10.006","volume":"9","author":"A Ebringer","year":"2010","unstructured":"Ebringer A, Rashid T, Wilson C (2010) Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper. Autoimmun Rev 9:216\u2013223","journal-title":"Autoimmun Rev"},{"key":"8424_CR96","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","volume":"30","author":"PK Gregersen","year":"1987","unstructured":"Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205\u20131213","journal-title":"Arthritis Rheum"},{"key":"8424_CR97","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1084\/jem.181.5.1847","volume":"181","author":"J Hammer","year":"1995","unstructured":"Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J, Valsasnini P, Nagy ZA, Sinigaglia F (1995) Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med 181:1847\u20131855","journal-title":"J Exp Med"},{"key":"8424_CR98","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0140-6736(95)91727-6","volume":"346","author":"H Baum","year":"1995","unstructured":"Baum H, Wilson C, Tiwana H, Ahmadi K, Ebringer A (1995) HLA association with autoimmune disease: restricted binding or T-cell selection? Lancet 346:1042\u20131043","journal-title":"Lancet"},{"key":"8424_CR99","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0167-5699(97)84245-4","volume":"18","author":"C Wilson","year":"1997","unstructured":"Wilson C, Tiwana H, Ebringer A, Cunningham P, Ettelaie C (1997) HLA-DR4 restriction, molecular mimicry and rheumatoid arthritis. Immunol Today 18:96\u201397","journal-title":"Immunol Today"},{"key":"8424_CR100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0167-5699(96)30021-2","volume":"17","author":"C Roudier","year":"1996","unstructured":"Roudier C, Auger I, Roudier J (1996) Molecular mimicry reflected through database screening: serendipity or survival strategy? Immunol Today 17:357\u2013358","journal-title":"Immunol Today"},{"key":"8424_CR101","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","volume":"171","author":"JA Hill","year":"2003","unstructured":"Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E (2003) Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 171:538\u2013541","journal-title":"J Immunol"},{"key":"8424_CR102","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.coi.2012.10.004","volume":"24","author":"J Choi","year":"2012","unstructured":"Choi J, Kim ST, Craft J (2012) The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol 24:651\u2013657","journal-title":"Curr Opin Immunol"},{"key":"8424_CR103","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.coi.2004.09.001","volume":"16","author":"SM Anderton","year":"2004","unstructured":"Anderton SM (2004) Post-translational modifications of self antigens: implications for autoimmunity. Curr Opin Immunol 16:753\u2013758","journal-title":"Curr Opin Immunol"},{"key":"8424_CR104","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaut.2010.06.016","volume":"35","author":"JG Routsias","year":"2010","unstructured":"Routsias JG, Tzioufas AG (2010) B-cell epitopes of the intracellular autoantigens Ro\/SSA and La\/SSB: tools to study the regulation of the autoimmune response. J Autoimmun 35:256\u2013264","journal-title":"J Autoimmun"},{"key":"8424_CR105","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2249.2006.03088.x","volume":"144","author":"AG Terzoglou","year":"2006","unstructured":"Terzoglou AG, Routsias JG, Avrameas S, Moutsopoulos HM, Tzioufas AG (2006) Preferential recognition of the phosphorylated major linear B-cell epitope of La\/SSB 349-368 aa by anti-La\/SSB autoantibodies from patients with systemic autoimmune diseases. Clin Exp Immunol 144:432\u2013439","journal-title":"Clin Exp Immunol"},{"key":"8424_CR106","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1568-9972(03)00018-1","volume":"2","author":"GW Zieve","year":"2003","unstructured":"Zieve GW, Khusial PR (2003) The anti-Sm immune response in autoimmunity and cell biology. Autoimmun Rev 2:235\u2013240","journal-title":"Autoimmun Rev"},{"key":"8424_CR107","doi-asserted-by":"crossref","first-page":"17122","DOI":"10.1074\/jbc.M000300200","volume":"275","author":"H Brahms","year":"2000","unstructured":"Brahms H, Raymackers J, Union A, de Keyser F, Meheus L, Luhrmann R (2000) The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies. J Biol Chem 275:17122\u201317129","journal-title":"J Biol Chem"},{"key":"8424_CR108","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/clim.1999.4745","volume":"92","author":"SO Hoch","year":"1999","unstructured":"Hoch SO, Eisenberg RA, Sharp GC (1999) Diverse antibody recognition patterns of the multiple Sm-D antigen polypeptides. Clin Immunol 92:203\u2013208","journal-title":"Clin Immunol"},{"key":"8424_CR109","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2249.1990.tb03327.x","volume":"81","author":"S Barakat","year":"1990","unstructured":"Barakat S, Briand JP, Weber JC, van Regenmortel MH, Muller S (1990) Recognition of synthetic peptides of Sm-D autoantigen by lupus sera. Clin Exp Immunol 81:256\u2013262","journal-title":"Clin Exp Immunol"},{"key":"8424_CR110","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/art.22646","volume":"56","author":"JW Dieker","year":"2007","unstructured":"Dieker JW, Fransen JH, van Bavel CC, Briand JP, Jacobs CW, Muller S, Berden JH, van der Vlag J (2007) Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum 56:1921\u20131933","journal-title":"Arthritis Rheum"},{"key":"8424_CR111","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.molimm.2009.08.009","volume":"47","author":"CC Bavel van","year":"2009","unstructured":"van Bavel CC, Dieker J, Muller S, Briand JP, Monestier M, Berden JH, van der Vlag J (2009) Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies. Mol Immunol 47:511\u2013516","journal-title":"Mol Immunol"},{"key":"8424_CR112","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/08916934.2012.710859","volume":"46","author":"HA Doyle","year":"2013","unstructured":"Doyle HA, Aswad DW, Mamula MJ (2013) Autoimmunity to isomerized histone H2B in systemic lupus erythematosus. Autoimmunity 46:6\u201313","journal-title":"Autoimmunity"},{"key":"8424_CR113","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.autrev.2005.12.004","volume":"5","author":"J Akaogi","year":"2006","unstructured":"Akaogi J, Barker T, Kuroda Y, Nacionales DC, Yamasaki Y, Stevens BR, Reeves WH, Satoh M (2006) Role of non-protein amino acid L-canavanine in autoimmunity. Autoimmun Rev 5:429\u2013435","journal-title":"Autoimmun Rev"},{"key":"8424_CR114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1104\/pp.94.1.1","volume":"94","author":"GA Rosenthal","year":"1990","unstructured":"Rosenthal GA (1990) Metabolism of l-canavanine and l-canaline in leguminous plants. Plant Physiol 94:1\u20133","journal-title":"Plant Physiol"},{"key":"8424_CR115","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-291X(02)00650-2","volume":"295","author":"MH Jang","year":"2002","unstructured":"Jang MH, Jun DY, Rue SW, Han K, Park W, Kim YH (2002) Arginine antimetabolite L-canavanine induces apoptotic cell death in human Jurkat T cells via caspase-3 activation regulated by Bcl-2 or Bcl-xL. Biochem Biophys Res Commun 295:283\u2013288","journal-title":"Biochem Biophys Res Commun"},{"key":"8424_CR116","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.7071589","volume":"216","author":"MR Malinow","year":"1982","unstructured":"Malinow MR, Bardana EJ Jr, Pirofsky B, Craig S, McLaughlin P (1982) Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science 216:415\u2013417","journal-title":"Science"},{"key":"8424_CR117","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/art.1780280109","volume":"28","author":"J Alcocer-Varela","year":"1985","unstructured":"Alcocer-Varela J, Iglesias A, Llorente L, Alarcon-Segovia D (1985) Effects of L-canavanine on T cells may explain the induction of systemic lupus erythematosus by alfalfa. Arthritis Rheum 28:52\u201357","journal-title":"Arthritis Rheum"},{"key":"8424_CR118","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/rheumatology\/41.5.563","volume":"41","author":"AA Bengtsson","year":"2002","unstructured":"Bengtsson AA, Rylander L, Hagmar L, Nived O, Sturfelt G (2002) Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology (Oxford) 41:563\u2013571","journal-title":"Rheumatology (Oxford)"},{"key":"8424_CR119","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nm1167","volume":"11","author":"MT McClain","year":"2005","unstructured":"McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA (2005) Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 11:85\u201389","journal-title":"Nat Med"},{"key":"8424_CR120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/BOR.0b013e3283535801","volume":"24","author":"JA James","year":"2012","unstructured":"James JA, Robertson JM (2012) Lupus and Epstein-Barr. Curr Opin Rheumatol 24:383\u2013388","journal-title":"Curr Opin Rheumatol"},{"key":"8424_CR121","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/cei.12022","volume":"171","author":"D Csuka","year":"2013","unstructured":"Csuka D, Simon D, Hobor R, Uray K, Prohaszka Z, Banlaki Z, Jani PK, Szilagyi A, Hudecz F, Rajczy K, Beke G, Boros Major A, Tordai A, Illes Z, Berki T, Czirjak L, Fust G (2013) Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis. Clin Exp Immunol 171:255\u2013262","journal-title":"Clin Exp Immunol"},{"key":"8424_CR122","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaut.2004.06.001","volume":"23","author":"K Sundar","year":"2004","unstructured":"Sundar K, Jacques S, Gottlieb P, Villars R, Benito ME, Taylor DK, Spatz LA (2004) Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J Autoimmun 23:127\u2013140","journal-title":"J Autoimmun"},{"key":"8424_CR123","doi-asserted-by":"crossref","first-page":"e14488","DOI":"10.1371\/journal.pone.0014488","volume":"6","author":"P Yadav","year":"2011","unstructured":"Yadav P, Tran H, Ebegbe R, Gottlieb P, Wei H, Lewis RH, Mumbey-Wafula A, Kaplan A, Kholdarova E, Spatz L (2011) Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One 6:e14488","journal-title":"PLoS One"},{"key":"8424_CR124","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.coviro.2013.03.003","volume":"3","author":"F Wang","year":"2013","unstructured":"Wang F (2013) Nonhuman primate models for Epstein-Barr virus infection. Curr Opin Virol 3:233\u2013237","journal-title":"Curr Opin Virol"},{"key":"8424_CR125","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.autrev.2008.12.008","volume":"8","author":"BD Poole","year":"2009","unstructured":"Poole BD, Templeton AK, Guthridge JM, Brown EJ, Harley JB, James JA (2009) Aberrant Epstein-Barr viral infection in systemic lupus erythematosus. Autoimmun Rev 8:337\u2013342","journal-title":"Autoimmun Rev"},{"key":"8424_CR126","doi-asserted-by":"crossref","first-page":"683489","DOI":"10.1155\/2008\/683489","volume":"2008","author":"W Zhang","year":"2008","unstructured":"Zhang W, Reichlin M (2008) A possible link between infection with Burkholderia bacteria and systemic lupus erythematosus based on epitope mimicry. Clin Dev Immunol 2008:683489","journal-title":"Clin Dev Immunol"},{"key":"8424_CR127","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DEG PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295\u2013306","journal-title":"J Thromb Haemost"},{"key":"8424_CR128","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0028-1082267","volume":"34","author":"SS Pierangeli","year":"2008","unstructured":"Pierangeli SS, Chen PP, Raschi E, Scurati S, Grossi C, Borghi MO, Palomo I, Harris EN, Meroni PL (2008) Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost 34:236\u2013250","journal-title":"Semin Thromb Hemost"},{"key":"8424_CR129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.thromres.2004.07.017","volume":"114","author":"S Miyakis","year":"2004","unstructured":"Miyakis S, Giannakopoulos B, Krilis SA (2004) Beta 2 glycoprotein I\u2014function in health and disease. Thromb Res 114:335\u2013346","journal-title":"Thromb Res"},{"key":"8424_CR130","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","volume":"335","author":"M Galli","year":"1990","unstructured":"Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ, Barbui T, Zwaal RF, Bevers EM (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335:1544\u20131547","journal-title":"Lancet"},{"key":"8424_CR131","first-page":"267","volume":"62","author":"PG Groot de","year":"2004","unstructured":"de Groot PG, Derksen RH (2004) Pathophysiology of antiphospholipid antibodies. Neth J Med 62:267\u2013272","journal-title":"Neth J Med"},{"key":"8424_CR132","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood-2009-12-260976","volume":"116","author":"C Agar","year":"2011","unstructured":"Agar C, van Os GM, Morgelin M, Sprenger RR, Marquart JA, Urbanus RT, Derksen RH, Meijers JC, de Groot PG (2011) Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood 116:1336\u20131343","journal-title":"Blood"},{"issue":"Suppl 1","key":"8424_CR133","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1538-7836.2011.04301.x","volume":"9","author":"FH Passam","year":"2011","unstructured":"Passam FH, Giannakopoulos B, Mirarabshahi P, Krilis SA (2011) Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I. J Thromb Haemost 9(Suppl 1):275\u2013282","journal-title":"J Thromb Haemost"},{"key":"8424_CR134","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","volume":"368","author":"B Giannakopoulos","year":"2013","unstructured":"Giannakopoulos B, Krilis SA (2013) The pathogenesis of the antiphospholipid syndrome. N Engl J Med 368:1033\u20131044","journal-title":"N Engl J Med"},{"key":"8424_CR135","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.10542","volume":"46","author":"J Delgado Alves","year":"2002","unstructured":"Delgado Alves J, Ames PR, Donohue S, Stanyer L, Nourooz-Zadeh J, Ravirajan C, Isenberg DA (2002) Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Arthritis Rheum 46:2686\u20132694","journal-title":"Arthritis Rheum"},{"key":"8424_CR136","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jama.2009.1346","volume":"302","author":"M Charakida","year":"2009","unstructured":"Charakida M, Besler C, Batuca JR, Sangle S, Marques S, Sousa M, Wang G, Tousoulis D, Delgado Alves J, Loukogeorgakis SP, Mackworth-Young C, D'Cruz D, Luscher T, Landmesser U, Deanfield JE (2009) Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome. JAMA 302:1210\u20131217","journal-title":"JAMA"},{"key":"8424_CR137","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1055\/s-0037-1615012","volume":"79","author":"PR Ames","year":"1998","unstructured":"Ames PR, Nourooz-Zadeh J, Tommasino C, Alves J, Brancaccio V, Anggard EE (1998) Oxidative stress in primary antiphospholipid syndrome. Thromb Haemost 79:447\u2013449","journal-title":"Thromb Haemost"},{"key":"8424_CR138","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/art.30383","volume":"63","author":"Y Ioannou","year":"2011","unstructured":"Ioannou Y, Zhang JY, Qi M, Gao L, Qi JC, Yu DM, Lau H, Sturgess AD, Vlachoyiannopoulos PG, Moutsopoulos HM, Rahman A, Pericleous C, Atsumi T, Koike T, Heritier S, Giannakopoulos B, Krilis SA (2011) Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen beta2-glycoprotein I. Arthritis Rheum 63:2774\u20132782","journal-title":"Arthritis Rheum"},{"key":"8424_CR139","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jprot.2009.08.007","volume":"73","author":"A Kondo","year":"2009","unstructured":"Kondo A, Miyamoto T, Yonekawa O, Giessing AM, Osterlund EC, Jensen ON (2009) Glycopeptide profiling of beta-2-glycoprotein I by mass spectrometry reveals attenuated sialylation in patients with antiphospholipid syndrome. J Proteomics 73:123\u2013133","journal-title":"J Proteomics"},{"key":"8424_CR140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11926-010-0151-9","volume":"13","author":"B Giannakopoulos","year":"2011","unstructured":"Giannakopoulos B, Mirarabshahi P, Krilis SA (2011) New insights into the biology and pathobiology of beta2-glycoprotein I. Curr Rheumatol Rep 13:90\u201395","journal-title":"Curr Rheumatol Rep"},{"key":"8424_CR141","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.blre.2007.09.001","volume":"22","author":"RT Urbanus","year":"2008","unstructured":"Urbanus RT, Derksen RH, de Groot PG (2008) Current insight into diagnostics and pathophysiology of the antiphospholipid syndrome. Blood Rev 22:93\u2013105","journal-title":"Blood Rev"},{"key":"8424_CR142","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00281-012-0321-0","volume":"34","author":"F Koning","year":"2012","unstructured":"Koning F (2012) Celiac disease: quantity matters. Semin Immunopathol 34:541\u2013549","journal-title":"Semin Immunopathol"},{"key":"8424_CR143","doi-asserted-by":"crossref","first-page":"174354","DOI":"10.4061\/2010\/174354","volume":"2010","author":"I Caputo","year":"2010","unstructured":"Caputo I, Lepretti M, Martucciello S, Esposito C (2010) Enzymatic strategies to detoxify gluten: implications for celiac disease. Enzyme Res 2010:174354","journal-title":"Enzyme Res"},{"key":"8424_CR144","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.immunol.18.1.53","volume":"18","author":"LM Sollid","year":"2000","unstructured":"Sollid LM (2000) Molecular basis of celiac disease. Annu Rev Immunol 18:53\u201381","journal-title":"Annu Rev Immunol"},{"key":"8424_CR145","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3748\/wjg.v18.i12.1348","volume":"18","author":"DH Dewar","year":"2012","unstructured":"Dewar DH, Donnelly SC, McLaughlin SD, Johnson MW, Ellis HJ, Ciclitira PJ (2012) Celiac disease: management of persistent symptoms in patients on a gluten-free diet. World J Gastroenterol 18:1348\u20131356","journal-title":"World J Gastroenterol"},{"key":"8424_CR146","first-page":"39","volume":"36","author":"A Blanco","year":"1995","unstructured":"Blanco A (1995) Gen\u00e9tica de la Enfermedad Celiaca. Bol Pediatr 36:39\u201350","journal-title":"Bol Pediatr"},{"key":"8424_CR147","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1056\/NEJMoa0807917","volume":"359","author":"DJ Smyth","year":"2008","unstructured":"Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C, Heap GA, Dubois PC, Clayton DG, Hunt KA, van Heel DA, Todd JA (2008) Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 359:2767\u20132777","journal-title":"N Engl J Med"},{"key":"8424_CR148","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1590\/S1807-59322009001200009","volume":"64","author":"E Caglar","year":"2009","unstructured":"Caglar E, Ugurlu S, Ozenoglu A, Can G, Kadioglu P, Dobrucali A (2009) Autoantibody frequency in celiac disease. Clinics (Sao Paulo) 64:1195\u20131200","journal-title":"Clinics (Sao Paulo)"},{"key":"8424_CR149","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00281-012-0312-1","volume":"34","author":"V Kumar","year":"2012","unstructured":"Kumar V, Wijmenga C, Withoff S (2012) From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases. Semin Immunopathol 34:567\u2013580","journal-title":"Semin Immunopathol"},{"key":"8424_CR150","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.coi.2011.08.006","volume":"23","author":"LM Sollid","year":"2011","unstructured":"Sollid LM, Jabri B (2011) Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders. Curr Opin Immunol 23:732\u2013738","journal-title":"Curr Opin Immunol"},{"key":"8424_CR151","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.4049\/jimmunol.1101526","volume":"187","author":"SW Qiao","year":"2011","unstructured":"Qiao SW, Raki M, Gunnarsen KS, Loset GA, Lundin KE, Sandlie I, Sollid LM (2011) Posttranslational modification of gluten shapes TCR usage in celiac disease. J Immunol 187:3064\u20133071","journal-title":"J Immunol"},{"key":"8424_CR152","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1053\/j.gastro.2005.02.018","volume":"128","author":"KO Bushara","year":"2005","unstructured":"Bushara KO (2005) Neurologic presentation of celiac disease. Gastroenterology 128:S92\u2013S97","journal-title":"Gastroenterology"},{"key":"8424_CR153","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1155\/2011\/642452","volume":"25","author":"D Armstrong","year":"2011","unstructured":"Armstrong D, Don-Wauchope AC, Verdu EF (2011) Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity. Can J Gastroenterol 25:193\u2013197","journal-title":"Can J Gastroenterol"},{"key":"8424_CR154","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.108","volume":"49","author":"KO Bushara","year":"2001","unstructured":"Bushara KO, Goebel SU, Shill H, Goldfarb LG, Hallett M (2001) Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol 49:540\u2013543","journal-title":"Ann Neurol"},{"key":"8424_CR155","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.4049\/jimmunol.178.10.6590","volume":"178","author":"A Alaedini","year":"2007","unstructured":"Alaedini A, Okamoto H, Briani C, Wollenberg K, Shill HA, Bushara KO, Sander HW, Green PH, Hallett M, Latov N (2007) Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I. J Immunol 178:6590\u20136595","journal-title":"J Immunol"},{"key":"8424_CR156","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","volume":"377","author":"C Selmi","year":"2011","unstructured":"Selmi C, Bowlus CL, Gershwin ME, Coppel RL (2011) Primary biliary cirrhosis. Lancet 377:1600\u20131609","journal-title":"Lancet"},{"key":"8424_CR157","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0016-5085(98)70375-0","volume":"115","author":"MJ Howard","year":"1998","unstructured":"Howard MJ, Fuller C, Broadhurst RW, Perham RN, Tang JG, Quinn J, Diamond AG, Yeaman SJ (1998) Three-dimensional structure of the major autoantigen in primary biliary cirrhosis. Gastroenterology 115:139\u2013146","journal-title":"Gastroenterology"},{"key":"8424_CR158","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jmb.2010.03.043","volume":"399","author":"S Vijayakrishnan","year":"2010","unstructured":"Vijayakrishnan S, Kelly SM, Gilbert RJ, Callow P, Bhella D, Forsyth T, Lindsay JG, Byron O (2010) Solution structure and characterisation of the human pyruvate dehydrogenase complex core assembly. J Mol Biol 399:71\u201393","journal-title":"J Mol Biol"},{"key":"8424_CR159","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2012.12.007","volume":"41","author":"PS Leung","year":"2013","unstructured":"Leung PS, Wang J, Naiyanetr P, Kenny TP, Lam KS, Kurth MJ, Gershwin ME (2013) Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA. J Autoimmun 41:79\u201386","journal-title":"J Autoimmun"},{"key":"8424_CR160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jaut.2011.06.001","volume":"37","author":"P Naiyanetr","year":"2011","unstructured":"Naiyanetr P, Butler JD, Meng L, Pfeiff J, Kenny TP, Guggenheim KG, Reiger R, Lam K, Kurth MJ, Ansari AA, Coppel RL, Lopez-Hoyos M, Gershwin ME, Leung PS (2011) Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity. J Autoimmun 37:209\u2013216","journal-title":"J Autoimmun"},{"key":"8424_CR161","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1172\/JCI200110716","volume":"108","author":"JA Odin","year":"2001","unstructured":"Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A (2001) Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 108:223\u2013232","journal-title":"J Clin Invest"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-014-8424-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-014-8424-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-014-8424-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T07:14:16Z","timestamp":1689232456000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-014-8424-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,21]]},"references-count":161,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["8424"],"URL":"https:\/\/doi.org\/10.1007\/s12016-014-8424-0","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,21]]}}}